Search

Your search keyword '"Hovingh, G. Kees"' showing total 1,375 results

Search Constraints

Start Over You searched for: Author "Hovingh, G. Kees" Remove constraint Author: "Hovingh, G. Kees"
1,375 results on '"Hovingh, G. Kees"'

Search Results

3. Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study

6. Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial

7. Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial

8. Cardiovascular outcomes in patients with homozygous familial hypercholesterolaemia on lipoprotein apheresis initiated during childhood: long-term follow-up of an international cohort from two registries

11. Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis

12. Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials

14. Age- and sex-based heterogeneity in coronary artery plaque presence and burden in familial hypercholesterolemia: A multi-national study

15. Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study

18. Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study

21. Atorvastatin Has a Dose‐Dependent Beneficial Effect on Kidney Function and Associated Cardiovascular Outcomes: Post Hoc Analysis of 6 Double‐Blind Randomized Controlled Trials

22. Paediatric patients with heterozygous familial hypercholesterolaemia treated with evolocumab for 80 weeks (HAUSER-OLE): a single-arm, multicentre, open-label extension of HAUSER-RCT

29. Relationship of lipoprotein-associated apolipoprotein C-III with lipid variables and coronary artery disease risk: The EPIC-Norfolk prospective population study

30. Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the TNT Trial

31. Adverse effects of statin therapy: perception vs. the evidence – focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract

32. Effect of atorvastatin, cholesterol ester transfer protein inhibition, and diabetes mellitus on circulating proprotein subtilisin kexin type 9 and lipoprotein(a) levels in patients at high cardiovascular risk

33. Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial

34. Decreased LDL cholesterol exposure following ANGPTL3 inhibition reduces coronary plaque development in Homozygous Familial Hypercholesterolemia

35. Semaglutide in Patients with Obesity-Related Heart Failure and Type 2 Diabetes

36. Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial

37. Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

40. GPIHBP1 autoantibodies in a patient with unexplained chylomicronemia

41. Meta-analysis of genome-wide association studies of HDL cholesterol response to statins

42. Age- and sex-based heterogeneity in coronary artery plaque presence and burden in familial hypercholesterolemia:A multi-national study

43. Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction:a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials

44. A neutralizing antibody against DKK1 does not reduce plaque formation in classical murine models of atherosclerosis: Is the therapeutic potential lost in translation?

50. Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement

Catalog

Books, media, physical & digital resources